Key points are not available for this paper at this time.
Design
Review
Provides targeted exam review material; leaves open integration into evolving clinical guidelines.
Retroperitoneal sarcomas (RS) are malignant tumors arising from mesenchymal cells, which are usually located in adipose, muscle, or connective tissue. RSs represent approximately 15% of all sarcomas and approximately 33–55% of all retroperitoneal tumors. The most common variants of RS include liposarcoma (40%), leiomyosarcoma (30%), and malignant fibrous histiocytoma (<10%). This article reviews the most important clinical characteristics of RSs, focusing on high-yield facts frequently encountered on standardized exams. The following core competencies are addressed in this article: Medical knowledge, Patient care. Republished with permission from: Stawicki SP. Retroperitoneal sarcomas. OPUS 12 Scientist 2007;1(1):17.
No takes yet. Share an insight, caveat, or question.
Stanislaw P. Stawicki (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: